ExGen Dx
PrivateLast Round
Grant
Jun 9, 2025
Total Funding Raised
$1.75M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ExGen Dx is a biotechnology company that develops rapid, point-of-care diagnostic tests for infectious diseases, particularly sexually transmitted infections, using its proprietary EXPAR and linear dichroism technologies.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Sensors
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExGen Dx Comparables
Compare ExGen Dx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rapidemic | 86% | |
| binx health | 81% | |
| Visby Medical | 78% | |
ExGen Dx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 9, 2025 | ||||
| VC Round | Feb 24, 2021 | ||||
| VC Round | Nov 14, 2019 | ||||
| Seed | May 24, 2017 |
ExGen Dx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Planet Capital Regional | VC Round |
| Midven | VC Round |
| British Business Bank | VC Round |
| UK Innovation & Science Seed Fund | Seed, VC Round |
| National Institute for Health and Care Research | Grant |
| University of Birmingham Enterprise | Seed |
| University of Birmingham | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 517% MoM, reaching 1.1K.
- Jun 9, 2025
$1.36M grant from the National Institute for Health and Care Research.
ExGen Dx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ExGen Dx's valuation, stock price, and market status.